Products

WT-1 – MMab

IHC of WT1 on an FFPE Testicular Cancer Tissue

IHC of WT1 on a FFPE Testicular Cancer Tissue

Specification Sheets
Safety Data Sheet
Intended UseFor In Vitro Diagnostic Use
Summary and ExplanationWilms’ Tumor Protein (WT1) is a suppressor gene located on Chromosome 11p13. Mutations of the WT1 gene on Chromosome 11 are observed in approximately 20% of Wilms tumors. At least half of the Wilms tumors with mutations in WT1 also carry mutations in CTNNB1, the gene encoding the proto-oncogene beta-catenin.
Wilms’ tumor is a neoplasm of the kidneys that typically occurs in children. It is also known as a Nephroblastoma. WT1 has been identified in proliferative mesothelial cells, Malignant Mesothelioma, Ovarian Cystadenocarcinoma,
Gonadoblastoma, Nephroblastoma and Desmoplastic Small Round Cell Tumor. Lung Adenocarcinomas rarely stain positive with this antibody.
Antibody TypeMouse MonoclonalClone6F-H2
IsotypeIgG1/KReactivityParaffin, Frozen
LocalizationNuclearControlTesticle, Fallopian Tube, Kidney, Malignant Mesothelioma
PresentationWT1 is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.
Availability
Catalog No.Antibody TypeDilutionVolume/QTY
BSB 6029PredilutedReady-To-Use3.0 ml
BSB 6030PredilutedReady-To-Use7.0 ml
BSB 6031PredilutedReady-To-Use15.0 ml
BSB 6032Concentrated1:100-1:5000.1 ml
BSB 6033Concentrated1:100-1:5000.5 ml
BSB 6034Concentrated1:100-1:5001.0 ml
BSB 6035Control Slides5
Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.

Related products

Skip to content